ReviewInternational journal of molecular sciences2020

The GPR17 Receptor-A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis.

Angela Dziedzic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.